E-DRUG Archives (by thread)

  • [e-drug] Second ICIUM Conference, Thailand, 2004, John Chalker
  • [e-drug] Thalidomide's Nationwide Usage (cont), Vanda Zidoniene
  • [e-drug] Better access to information, Valeria Frighi
  • [e-drug] Research paper available: the hidden costs of procuring essential medicines, Libby Levison
  • [e-drug] Restored sensitivity to older antibacterials?, Valeria Frighi
  • [e-drug] CPTech filing in South Africa competition commission case, James Love
  • [e-drug] E-learning Course on Health Outcomes and the Poor, Jo Hindriks
  • [e-drug] Research paper available(cont), Libby Levison
  • [e-drug] MSF Letter to the Editor in NYT re: meningitis vaccine, Rachel COHEN
  • [e-drug] Police bust heads in Korea today over Glivic drug protest, James Love
  • [e-drug] Letter to the Delegates to the WTO, Philippe Swennen
  • [e-drug] The impact of applicability of ICH guidelines in developing, abenfeddoul
  • [e-drug] WHO publication on ICH, WilbertBannenberg
  • [e-drug] Open letter to the WTO from Médecins sans Frontières, ellen . t . hoen
  • [e-drug] ICH and women, WilbertBannenberg
  • [e-drug] Rational Drug Management course in International Health, Dr. Reinhard Huss
  • [e-drug] Use of cell phones for TB compliance, Dr. David Green
  • [e-drug] new Global Fund approvals list, e-drug
  • [e-drug] Donating books and journals to less developed countries, e-drug
  • [e-drug] Study: revolving drug funds, Gamal Khalafalla Mohammed
  • [e-drug] Community revolving drug schemes, Vera Lucia Luiza
  • [e-drug] Can human rights serve as a tool for equality? Work in progress, richardl
  • [e-drug] Research paper on hidden drug costs, Hilbrand Haak
  • [e-drug] Therapeutics Letter 46: Menopausal Combined Hormone Therapy Update, Ciprian Jauca
  • [e-drug] MSF open letter to S. African govt for a national treatment plan, Marta Darder
  • [e-drug] Research paper on hidden drug costs (cont), owner-e-drug
  • [e-drug] Internet access still a nightmare in Africa, A. Odutola
  • [e-drug] 2nd Asian Course on Problem-Based Pharmacotherapy Teaching, Kathleen Holloway
  • [e-drug] Sell-out at WTO on Doha declaration?, ingrid . cox
  • [e-drug] Lancet: A positive result for AIDS, e-drug
  • [e-drug] ICH guidelines (cont), Kirsten Myhr
  • [e-drug] Roche finally lowers price of nelfinavir, mpalmedo
  • [e-drug] WHO EDL Committee agenda 31 march - 3 April 2003, e-drug
  • [e-drug] WHO Expert Committee on the Selection and Use of Essential, grayr
  • [e-drug] RUD course (French): change of date & venue, hollowayk
  • [e-drug] Understanding TRIPS (Patents & Access to Drugs), e-drug
  • [e-drug] WHO EDL Committee agenda 31 march - 3 April 2003 (cont), stein
  • [e-drug] Training for the Developing World: Can't WHO help?, Kibumba George
  • [e-drug] Training for the Developing World: Can't WHO help? (cont), ragol
  • [e-drug] Origins of AIDS and inappropriate use of injections, Hilbrand Haak
  • [e-drug] Short course on ARV therapy, Lut Lynen
  • [e-drug] Counterfeit drugs? contact WHO, e-drug
  • [e-drug] Origins of AIDS (cont), Beverley Snell
  • [e-drug] WHO position vacant, Guitelle Baghdadi
  • [e-drug] WHO EML Committee agenda 31 march - 3 April 2003 (cont), grayr
  • [e-drug] Origins of AIDS (cont'd), Hilbrand Haak
  • [e-drug] WHO and training, hollowayk
  • [e-drug] WHO and training (cont), Perla Mordujovich
  • [e-drug] Origins of AIDS transmission (cont'd), Carolyn Green
  • [e-drug] WHO Indicators, Eurek Ranjit
  • [e-drug] Direct to Consumer Advertising, Joel Lexchin
  • [e-drug] WHO Indicators (cont), ahmed ayesha
  • [e-drug] Revolving Drug Fund Sudan, richardl
  • [e-drug] WHO & Training (cont), Geeta Pradeep
  • [e-drug] Re: ICH guidelines (cont), Kirsten Myhr
  • [e-drug] Revolving Drug Funds (cont), Owino, Wasunna
  • [e-drug] Drugs with narrow therapeutic index, Cimf
  • [e-drug] WHO and training (cont'd), Susan Foster
    • Mail converted by MHonArc 2.6.8